ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Moleculin Biotech Inc

Moleculin Biotech Inc (0K2H)

25.50
0.00
(0.00%)
Closed January 27 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
25.50
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
25.50 52 Week Range 25.50
Market Cap
Previous Close
25.50
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
264
Shares Outstanding
29,810,000
Dividend Yield
-
PE Ratio
-1.70
Earnings Per Share (EPS)
-1
Revenue
-
Net Profit
-29.77M

About Moleculin Biotech Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Moleculin Biotech Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0K2H. The last closing price for Moleculin Biotech was US$25.50. Over the last year, Moleculin Biotech shares have traded in a share price range of US$ 25.50 to US$ 25.50.

Moleculin Biotech currently has 29,810,000 shares outstanding. The market capitalization of Moleculin Biotech is US$760.16 million. Moleculin Biotech has a price to earnings ratio (PE ratio) of -1.70.

0K2H Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10025.525.525.55125.5DE
40025.525.525.519125.5DE
120025.525.525.526425.5DE
260025.525.525.520525.5DE
520025.525.525.532825.5DE
1560025.525.525.526025.5DE
2600025.525.525.534725.5DE

0K2H - Frequently Asked Questions (FAQ)

What is the current Moleculin Biotech share price?
The current share price of Moleculin Biotech is US$ 25.50
How many Moleculin Biotech shares are in issue?
Moleculin Biotech has 29,810,000 shares in issue
What is the market cap of Moleculin Biotech?
The market capitalisation of Moleculin Biotech is USD 760.16M
What is the 1 year trading range for Moleculin Biotech share price?
Moleculin Biotech has traded in the range of US$ 25.50 to US$ 25.50 during the past year
What is the PE ratio of Moleculin Biotech?
The price to earnings ratio of Moleculin Biotech is -1.7
What is the reporting currency for Moleculin Biotech?
Moleculin Biotech reports financial results in USD
What is the latest annual profit for Moleculin Biotech?
The latest annual profit of Moleculin Biotech is USD -29.77M
What is the registered address of Moleculin Biotech?
The registered address for Moleculin Biotech is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Moleculin Biotech website address?
The website address for Moleculin Biotech is www.moleculin.com
Which industry sector does Moleculin Biotech operate in?
Moleculin Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PPSProton Motor Power Systems Plc
0.325p
(85.71%)
4.07M
CTAICatenai Plc
0.255p
(34.21%)
79.48M
MILAMila Resources Plc
0.23p
(31.43%)
27.89M
SNGSynairgen Plc
2.34p
(26.66%)
6.36M
GILDGuild Esports Plc
0.05p
(25.00%)
34.84M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
EXREngage Xr Holdings Plc
1.55p
(-20.92%)
12.64M
RNWHRenew Holdings Plc
720.00p
(-20.79%)
2.45M
UKRUkrproduct Group Limited
2.00p
(-20.00%)
1.25k
PREMPremier African Minerals Limited
0.0245p
(-2.00%)
2.6B
TRPTower Resources Plc
0.0295p
(7.27%)
1.07B
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
RRRRed Rock Resources Plc
0.0525p
(-4.55%)
198.76M

Discussion

View Full Feed
boston127 boston127 4 minutes ago
WNW is in a strong bearish trend.

Shares are below a declining 200-day moving average and the MACD is beneath its signal line. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500.
WNW
dinogreeves dinogreeves 6 minutes ago
Market meltdown tomorrow.
SMCI
boston127 boston127 6 minutes ago
Momentum for WNW is strongly bearish.

The 14-period Slow Stochastic oscillator is below 20, the level which many analysts call oversold. This means that investors have been actively selling.
WNW
dinogreeves dinogreeves 7 minutes ago
https://finance.yahoo.com/news/chinese-ai-startup-deepseek-overtakes-053700426.html
SMCI
jhdf51 jhdf51 8 minutes ago
A diamond isn’t real until it is.
JHD
COOP
dinogreeves dinogreeves 8 minutes ago
Market meltdown because of this article. This is ridiculous

https://www.yahoo.com/finance/news/nasdaq-futures-slump-china-deepseek-022904517.html
NVDA
boston127 boston127 8 minutes ago
The company's value is negative $2M.

Must have been a P&D.
WNW
Stockman1010101 Stockman1010101 8 minutes ago
From what I understand. Only president Trump and Treasury Secretary Bessent need to authorize the release of the GSEs from Conservatorship. Sending a letter to Congress is a waste of time and foolish at best. Send it directly to President Trump if you want results done, People.

GLTA
FNMA
dinogreeves dinogreeves 10 minutes ago
This is shaking the market

https://www.yahoo.com/finance/news/nasdaq-futures-slump-china-deepseek-022904517.html
SMCI
hbhmb hbhmb 15 minutes ago
What is with the name calling you guys resort to when you disagree with someone you all sound like 2 nd graders sheesh
AIAD
boston127 boston127 16 minutes ago
NVNI is in a strong bullish trend.

Its 200-day moving average is upwards sloping and the MACD histogram is above 0 and rising. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
NVNI
robinandthe7hoods robinandthe7hoods 17 minutes ago
What has to be remembered is that Verses AI isn't even out of its beta phase yet.
Anybody name another o/s or any other tech that made a big splash before it was even out of beta testing?
VRSSF
Investor082 Investor082 21 minutes ago
It’s not a question of whether BP can afford it. They throw so much money on companies they are strategically interested in partnering. NWBO is just not one of them. And there are quite of these companies like NWBO as well.
NWBO
Steady_T Steady_T 21 minutes ago
I was unaware that he made that comment in reference to the EMA. I remember that in conjunction with discussion of the FDA.
My bad.
AVXL
Oleblue Oleblue 23 minutes ago
Initially celebrated for its groundbreaking speed and unmatched computational power, Willow suddenly became the center of mystery, speculation, and fear. Sources claim that scientists spotted something strange in its final data streams - anomalies that defied explanation. Then, an ethical hacker unc
GOOG
ramfan60 ramfan60 29 minutes ago
Well Nukem..... Allen did his part for Buffalo to win..... the receiver dropped a ball right in his hands on that last 4th down drive. Some questionable play calls as well from the Bills coach didn't help....... don't run Allen right into the meat of of KC line.....spread them out and let Allen run
AMRN
StockItOut StockItOut 34 minutes ago
He's pre-decided the end-story of his scam story, so then everything Xeriant does is a scam (except he wants Xeriant to play legit with an 8-K about XTI issued shares that were auto cancelled and turned into XTIA shares that he is too stupid to understand) so he fabricates to try to make it fit his
XTIA
StockItOut StockItOut 34 minutes ago
of course they own it. If not, who owns the shares issued to Xeriant?

Your claim never gets explained.

You're afraid your conclusion will unravel your fabricated story.
XERI
shajandr shajandr 36 minutes ago
https://www.spiked-online.com/2024/12/31/what-really-happened-in-wuhan/

Your Recent History

Delayed Upgrade Clock